Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies
Background: Recent studies have shown an increasing number of patients with cutaneous leishmaniasis (CL) who do not respond to pentavalent antimonials as the first line of treatment for CL. Nanocarriers such as extracellular vesicles (EVs) are efficient vehicles that might be used as drug delivery...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2023-11-01
|
| Series: | Iranian Journal of Parasitology |
| Subjects: | |
| Online Access: | https://ijpa.tums.ac.ir/index.php/ijpa/article/view/3853 |
| _version_ | 1797394713419972608 |
|---|---|
| author | Afshin Davari Homa Hajjaran Ali Khamesipour Mehdi Mohebali Fatemeh Mehryab Saeed Shahsavari Faezeh Shekari |
| author_facet | Afshin Davari Homa Hajjaran Ali Khamesipour Mehdi Mohebali Fatemeh Mehryab Saeed Shahsavari Faezeh Shekari |
| author_sort | Afshin Davari |
| collection | DOAJ |
| description |
Background: Recent studies have shown an increasing number of patients with cutaneous leishmaniasis (CL) who do not respond to pentavalent antimonials as the first line of treatment for CL. Nanocarriers such as extracellular vesicles (EVs) are efficient vehicles that might be used as drug delivery systems for the treatment of diseases. Therefore, we aimed to isolate and characterize the EVs of Leishmania major, load them with Amphotericin B (AmB), and investigate the toxicity and efficacy of the prepared drug form.
Methods: The EVs of L. major were isolated, characterized, and loaded with amphotericin B (AmB), and the EVs-Amphotericin B (EVs-AmB) form was synthesized. Relevant in vitro and in vivo methods were performed to evaluate the toxicity and efficacy of EVs-AmB compared to the control.
Results: The anti-leishmanial activity of the EVs-AmB showed a higher percentage inhibition (PI%) (P = 0.023) compared to the AmB at different concentrations and time points. Obtained data showed a significant increase in the lesion size and parasite load in the lesion, PBS, and EVs mice groups in comparison with EVs-AmB, AmB, and Glucantime groups (P < 0.05), EVs-AmB had a significant decrease in lesion sizes in comparison with AmB (P < 0.05). Results showed that EVs-AmB decreased its toxicity to the kidneys and liver (P < 0.05).
Conclusion: EVs-AmB improved the efficacy of AmB in mouse skin lesions and reduced hepatorenal toxicity. Furthermore, EVs could be a promising nanoplatform for the delivery of AmB in CL caused by L. major.
|
| first_indexed | 2024-03-09T00:23:44Z |
| format | Article |
| id | doaj.art-d956cc1bc91a4d7cba80c62bbf41de31 |
| institution | Directory Open Access Journal |
| issn | 1735-7020 2008-238X |
| language | English |
| last_indexed | 2024-03-09T00:23:44Z |
| publishDate | 2023-11-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Iranian Journal of Parasitology |
| spelling | doaj.art-d956cc1bc91a4d7cba80c62bbf41de312023-12-12T04:54:26ZengTehran University of Medical SciencesIranian Journal of Parasitology1735-70202008-238X2023-11-0118410.18502/ijpa.v18i4.14260Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo StudiesAfshin Davari0Homa Hajjaran1Ali Khamesipour2Mehdi Mohebali3Fatemeh Mehryab4Saeed Shahsavari5Faezeh Shekari6Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Scienc-es, Tehran, IranDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Scienc-es, Tehran, IranCenter for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran1. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 2. Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, IranDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology (ACECR), Tehran, IranDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, IranDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology (ACECR), Tehran, Iran Background: Recent studies have shown an increasing number of patients with cutaneous leishmaniasis (CL) who do not respond to pentavalent antimonials as the first line of treatment for CL. Nanocarriers such as extracellular vesicles (EVs) are efficient vehicles that might be used as drug delivery systems for the treatment of diseases. Therefore, we aimed to isolate and characterize the EVs of Leishmania major, load them with Amphotericin B (AmB), and investigate the toxicity and efficacy of the prepared drug form. Methods: The EVs of L. major were isolated, characterized, and loaded with amphotericin B (AmB), and the EVs-Amphotericin B (EVs-AmB) form was synthesized. Relevant in vitro and in vivo methods were performed to evaluate the toxicity and efficacy of EVs-AmB compared to the control. Results: The anti-leishmanial activity of the EVs-AmB showed a higher percentage inhibition (PI%) (P = 0.023) compared to the AmB at different concentrations and time points. Obtained data showed a significant increase in the lesion size and parasite load in the lesion, PBS, and EVs mice groups in comparison with EVs-AmB, AmB, and Glucantime groups (P < 0.05), EVs-AmB had a significant decrease in lesion sizes in comparison with AmB (P < 0.05). Results showed that EVs-AmB decreased its toxicity to the kidneys and liver (P < 0.05). Conclusion: EVs-AmB improved the efficacy of AmB in mouse skin lesions and reduced hepatorenal toxicity. Furthermore, EVs could be a promising nanoplatform for the delivery of AmB in CL caused by L. major. https://ijpa.tums.ac.ir/index.php/ijpa/article/view/3853Leishmania majorExtracellular vesiclesDrug deliveryAmphotericin BIn vitro and In vivo. |
| spellingShingle | Afshin Davari Homa Hajjaran Ali Khamesipour Mehdi Mohebali Fatemeh Mehryab Saeed Shahsavari Faezeh Shekari Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies Iranian Journal of Parasitology Leishmania major Extracellular vesicles Drug delivery Amphotericin B In vitro and In vivo. |
| title | Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies |
| title_full | Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies |
| title_fullStr | Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies |
| title_full_unstemmed | Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies |
| title_short | Amphotericin B-Loaded Extracellular Vesicles Derived from Leishmania major Enhancing Cutaneous Leishmaniasis Treatment through In Vitro and In Vivo Studies |
| title_sort | amphotericin b loaded extracellular vesicles derived from leishmania major enhancing cutaneous leishmaniasis treatment through in vitro and in vivo studies |
| topic | Leishmania major Extracellular vesicles Drug delivery Amphotericin B In vitro and In vivo. |
| url | https://ijpa.tums.ac.ir/index.php/ijpa/article/view/3853 |
| work_keys_str_mv | AT afshindavari amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies AT homahajjaran amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies AT alikhamesipour amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies AT mehdimohebali amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies AT fatemehmehryab amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies AT saeedshahsavari amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies AT faezehshekari amphotericinbloadedextracellularvesiclesderivedfromleishmaniamajorenhancingcutaneousleishmaniasistreatmentthroughinvitroandinvivostudies |